Literature DB >> 11890874

The genetics of systemic sclerosis.

Randall W Johnson1, Monty B Tew, Frank C Arnett.   

Abstract

The etiopathogenesis of systemic sclerosis (SSc) is unclear. With no definitive evidence supporting an environmental cause, recent attention has focused on genetic factors. Familial clustering and ethnic influences have been demonstrated. Human leukocyte antigen (HLA) associations exist but are more related to the presence of particular autoantibodies rather than to the disease. In addition, no single major histocompatibility complex (MHC) allele predisposes to SSc in all ethnic groups. The role of microchimerism in SSc is a novel yet unproven hypothesis that may be related to intergenerational HLA compatibility. Recent studies investigating polymorphisms in genes coding for extracellular matrix proteins and cell-signaling molecules implicate non-MHC areas in SSc pathogenesis. The data reviewed suggest that SSc is a multigenic complex disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890874     DOI: 10.1007/s11926-002-0004-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  76 in total

1.  Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity.

Authors:  N C Lambert; P C Evans; T L Hashizumi; S Maloney; T Gooley; D E Furst; J L Nelson
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.

Authors:  C M Artlett; J B Smith; S A Jimenez
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

Review 3.  Scleroderma epidemiology.

Authors:  M D Mayes
Journal:  Rheum Dis Clin North Am       Date:  1996-11       Impact factor: 2.670

4.  Microchimerism of maternal origin persists into adult life.

Authors:  S Maloney; A Smith; D E Furst; D Myerson; K Rupert; P C Evans; J L Nelson
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients.

Authors:  F Takeuchi; H Nabeta; M Füssel; K Conrad; K H Frank
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

6.  Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.

Authors:  M Kuwana; H Inoko; H Kameda; T Nojima; S Sato; K Nakamura; T Ogasawara; M Hirakata; Y Ohosone; J Kaburaki; Y Okano; T Mimori
Journal:  Intern Med       Date:  1999-04       Impact factor: 1.271

7.  Development of the tight-skin phenotype in immune-deficient mice.

Authors:  T D Dodig; K T Mack; D F Cassarino; S H Clark
Journal:  Arthritis Rheum       Date:  2001-03

8.  The mouse tight skin (Tsk) phenotype is not dependent on the presence of mature T and B lymphocytes.

Authors:  L D Siracusa; R McGrath; J K Fisher; S A Jimenez
Journal:  Mamm Genome       Date:  1998-11       Impact factor: 2.957

9.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

Authors:  S I Rennard; G W Hunninghake; P B Bitterman; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  The Tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils.

Authors:  C M Kielty; M Raghunath; L D Siracusa; M J Sherratt; R Peters; C A Shuttleworth; S A Jimenez
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

View more
  15 in total

1.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Authors:  Manuela Indelicato; Valentina Chiarenza; Massimo Libra; Grazia Malaponte; Valentina Bevelacqua; Maurizio Marchini; James A McCubrey; Franca Stivala; Raffaella Scorza; Maria Clorinda Mazzarino
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 3.  [Pathogenesis of systemic sclerosis].

Authors:  M Fabri; T Krieg
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

4.  Evaluation of interleukin 13 polymorphisms in systemic sclerosis.

Authors:  Brigitte Granel; Christophe Chevillard; Yannick Allanore; Violaine Arnaud; Sandrine Cabantous; Sandrine Marquet; Pierre-Jean Weiller; Jean-Marc Durand; Jean-Robert Harlé; Claire Grange; Yves Frances; Philippe Berbis; Jean Gaudart; Philippe de Micco; André Kahan; Alain Dessein
Journal:  Immunogenetics       Date:  2006-07-11       Impact factor: 2.846

Review 5.  Genetics and proteomics in scleroderma.

Authors:  Carol A Feghali-Bostwick
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 6.  [Scleroderma associated autoantibodies - clinical and diagnostic relevance].

Authors:  R Mierau; E Genth
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

7.  Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.

Authors:  E Scala; R Paganelli; F Sampogna; D Abeni; L Colonna; O De Pità; P Puddu; G Russo
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

8.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.

Authors:  Jadwiga Skretkowicz; Malgorzata Baranska; Mariola Rychlik-Sych
Journal:  Eur J Clin Pharmacol       Date:  2009-05-15       Impact factor: 2.953

9.  Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.

Authors:  G Balbi; F Ferrera; M Rizzi; P Piccioli; A Morabito; L Cardamone; M Ghio; G L Palmisano; P Carrara; S Pedemonte; M Sessarego; M De Angioletti; R Notaro; F Indiveri; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

10.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.